天美传媒

I specialize in the treatment of gastrointestinal (GI) cancers with a focus on clinical trials. Clinical trial patients can come to me at any point during their disease, but they usually come to me looking for an alternative therapy once standard treatments have not been effective. I decided to become a doctor later in my career. I originally graduated from university with a non-science degree, but the excitement of advancing medical breakthroughs inspired me to start a career in medicine. As a Duke physician, I enjoy the diverse experiences that I get to have each week. In addition to taking care of patients and conducting research, I work closely with other doctors on crafting treatment plans. I also find it fulfilling to be able to apply my research to patient care. In my spare time, I enjoy spending time with my family, jogging and skiing.
Education

Fellowship in Hematology-Oncology, MEDICINE - Duke University, School of Medicine
Residency, MEDICINE - University of Washington
M.D. 2005 - The University of Chicago

Michael Cecchini, MD, is a medical oncologist who specializes in gastrointestinal cancers, including (but not limited to) colorectal, bile duct, pancreas, esophageal, and stomach cancers. He often cares for patients with advanced gastrointestinal cancers and is an investigator in multiple research trials to help them get treatments that are not always available elsewhere.
“Taking care of patients and spending the time to get to know them is the best part of my job,” Dr. Cecchini says. It helps to draw upon the diverse expertise of colleagues at Smilow and those in non-cancer specialties, he adds. “At Yale we have an excellent multidisciplinary team that will work hard to treat your cancer, manage your symptoms, and deliver the care you deserve as a patient.”
Dr. Cecchini was inspired to become a cancer specialist partly because he wanted to have opportunities to perform research to improve options for his patients. “Few specialties are so integrated with close patient relationships and translational research that can dramatically improve the lives of our patients and minimize side effects,” he says. His translational research includes clinical and lab projects to study DNA damage and the immune response, primarily for colorectal cancer. He is the recipient of a Young Investigator Award from the Conquer Cancer Foundation for research focused on metastatic gastric cancer and 2020 Scholar on the Yale Cancer Center K12 Calabresi Immuno-Oncology Training Program.

 
Dr. David Bajor, is an oncologist in Cleveland, Ohio and is affiliated with multiple hospitals in the area, including  and . He received his medical degree from Case Western Reserve University School of Medicine and has been in practice between 11-20 years.